Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
---|---|---|---|---|---|---|---|
Imatinib Mesylate | hsa-miR-29a-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-494-3p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-660-5p | miRNA | sensitive | Low | Chronic Myelogenous Leukemia | Homo sapiens |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.
Compound | ncRNA | ncRNA Type | Pattern | Throughput | Phenotype | Species | Detail |
---|---|---|---|---|---|---|---|
Imatinib Mesylate | hsa-let-7c | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-125a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-125a-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-126-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-127-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-128-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-1285-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-132-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-142-3p | miRNA | down-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-142-3p | miRNA | down-regulated | High | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-146a-5p | miRNA | up-regulated | High | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-146a-5p | miRNA | up-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-146a-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-150-5p | miRNA | up-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-150-5p | miRNA | up-regulated | High | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-151a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-181a-5p | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-191-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-193a-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-199b-5p | miRNA | down-regulated | High | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-199b-5p | miRNA | down-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-20b-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-212-3p | miRNA | down-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-212-3p | miRNA | down-regulated | Low | Chronic Myeloid Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-218-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-23a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-30b-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-30c-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-320a-3p | miRNA | down-regulated | High | Normal | Homo sapiens | |
Imatinib Mesylate | hsa-miR-320b | miRNA | up-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-323a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-328-3p | miRNA | down-regulated | Low | Chronic myeloid leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-331-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-362-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-378 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-409-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-411-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-454-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-485-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-502-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-532-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-532-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-543 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-548j-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-550 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-574-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-589 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-598-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-604 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-616 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-671-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-708-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-92a-3p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | hsa-miR-941 | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Homo sapiens | |
Imatinib Mesylate | mmu-miR-140-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Mus musculus | |
Imatinib Mesylate | mmu-miR-491-5p | miRNA | down-regulated | Low | Chronic Myelogenous Leukemia | Mus musculus |
Due to slow loading speeds, networks with more than 100 edges will not be displayed.